A detailed history of Key F Inancial Inc transactions in Organon & Co. stock. As of the latest transaction made, Key F Inancial Inc holds 1,273 shares of OGN stock, worth $20,533. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,273
Previous 1,338 4.86%
Holding current value
$20,533
Previous $25,000 28.0%
% of portfolio
0.0%
Previous 0.01%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 31, 2025

SELL
$14.44 - $18.83 $938 - $1,223
-65 Reduced 4.86%
1,273 $18,000
Q3 2024

Oct 29, 2024

SELL
$18.65 - $23.03 $466 - $575
-25 Reduced 1.83%
1,338 $25,000
Q2 2024

Jul 29, 2024

SELL
$17.45 - $21.96 $3,315 - $4,172
-190 Reduced 12.23%
1,363 $28,000
Q1 2024

May 13, 2024

SELL
$13.78 - $18.8 $275 - $376
-20 Reduced 1.27%
1,553 $29,000
Q4 2023

Jan 31, 2024

SELL
$10.95 - $17.32 $372 - $588
-34 Reduced 2.12%
1,573 $22,000
Q3 2023

Nov 01, 2023

SELL
$16.59 - $23.77 $116 - $166
-7 Reduced 0.43%
1,607 $27,000
Q2 2023

Jul 28, 2023

BUY
$19.27 - $24.63 $231 - $295
12 Added 0.75%
1,614 $33,000
Q1 2023

May 02, 2023

SELL
$21.42 - $32.08 $23,219 - $34,774
-1,084 Reduced 40.36%
1,602 $37,000
Q3 2022

Oct 28, 2022

BUY
$23.4 - $34.25 $6,318 - $9,247
270 Added 11.18%
2,686 $63,000
Q2 2022

Jul 26, 2022

SELL
$31.66 - $38.9 $4,020 - $4,940
-127 Reduced 4.99%
2,416 $83,000
Q1 2022

Apr 27, 2022

BUY
$30.45 - $39.36 $1,522 - $1,968
50 Added 2.01%
2,543 $89,000
Q4 2021

Jan 19, 2022

BUY
$28.67 - $37.13 $286 - $371
10 Added 0.4%
2,493 $76,000
Q3 2021

Nov 01, 2021

BUY
$28.63 - $35.64 $5,783 - $7,199
202 Added 8.86%
2,483 $81,000
Q2 2021

Aug 02, 2021

BUY
$28.45 - $38.0 $64,894 - $86,678
2,281 New
2,281 $66,000

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $4.1B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Key F Inancial Inc Portfolio

Follow Key F Inancial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Key F Inancial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Key F Inancial Inc with notifications on news.